Anixa Biosciences

ANIXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$116.359 M

$3.42 -0.29%

Close of 7 Aug 2026

Revenue

$210.0K

#3589 by revenue

Earnings

-$10.9M

Loss-making

Shares outstanding

34,023,063

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#299GeneluxGNLX$119.3M
#300Cumberland PharmaceuticalsCPIX$116.9M
#301Anixa BiosciencesANIX$116.4M
#302Cue BiopharmaCUE$113.9M
#303Coya TherapeuticsCOYA$112.8M

Where these numbers come from

Share counts and financials for Anixa Biosciences are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.